Junko Tanizaki
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology
- Cancer Research top 10%
- Immunology top 10%
- Co-authors
- Kazuhiko NakagawaIsamu OkamotoHidetoshi HayashiKazuto NishioKazuko SakaiKaoru TanakaKoji HarataniMasayuki Takeda
- Topics
- Lung Cancer Treatments and Mutations (41 papers)Cancer Immunotherapy and Biomarkers (16 papers)Lung Cancer Research Studies (15 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Junko Tanizaki
66 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 1.7k
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 680
- Cancer Research 287
- Immunology 283
Countries citing papers authored by Junko Tanizaki
This map shows the geographic impact of Junko Tanizaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Tanizaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Tanizaki more than expected).
Fields of papers citing papers by Junko Tanizaki
This network shows the impact of papers produced by Junko Tanizaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Tanizaki. The network helps show where Junko Tanizaki may publish in the future.
Co-authorship network of co-authors of Junko Tanizaki
This figure shows the co-authorship network connecting the top 25 collaborators of Junko Tanizaki. A scholar is included among the top collaborators of Junko Tanizaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Tanizaki. Junko Tanizaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | 66 | |
| 10 | 49 | |
| 11 | 1 | |
| 12 | 172 | |
| 13 | 100 | |
| 14 | Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancerbreakdown → | 366 |
| 15 | 30 | |
| 16 | 9 | |
| 17 | 18 | |
| 18 | 126 | |
| 19 | 99 | |
| 20 | 63 |
About Junko Tanizaki
Junko Tanizaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (41 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Lung Cancer Research Studies (15 papers). The work is most often cited by research in Oncology (1.7k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Cancer Research (287 citations). Junko Tanizaki has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Kazuhiko Nakagawa, Isamu Okamoto, Hidetoshi Hayashi, Kazuto Nishio, Kazuko Sakai, Kaoru Tanaka, Koji Haratani, Masayuki Takeda, Akihiko Ito and Hisato Kawakami. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.